Combined effects of gender, skin type and polymorphic genes on clinical phenotype: Use of rate of increase in numbers of basal cell carcinomas as a model system

Cancer Letters

Volumn 189, Issue 2, 2003, Pages 175-181

  Ramachandran, Sudarshan ^a   Fryer, Anthony A ^b   Lovatt, Tracy J ^b   Smith, Andrew G ^c   Lear, John T ^c   Jones, Peter W ^d   Strange, Richard C ^b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

Basal cell carcinoma; Cytochrome P450; Polymorphism; Tumor necrosis factor alpha; Vitamin D receptor

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2D6; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENDER; GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SKIN;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CYTOCHROME P-450 CYP2D6; DNA, NEOPLASM; ENGLAND; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS; SKIN PIGMENTATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037469099     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00516-5     Document Type: Article

References (16)

1. Frankel W.N., Schork N.J. Who's afraid of epistasis? Nat. Genet. 14:1996;371-373.
2. Tripodis N., Hart A.A.M., Fijneman R.J.A., Demant P. Complexity of lung cancer modifiers: mapping of 30 genes and 25 interactions in half of the mouse genome. J. Natl. Cancer Inst. 93:2001;1484-1491.
3. Heagerty A.H.M., Fitzgerald D., Smith A., Bowers B., Jones P., Fryer A., Zhao L., Alldersea J., Strange R.C. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous malignancy. Lancet. 343:1994;266-268.
4. Ramachandran S., Lear J.T., Ramsay H., Smith A.G., Bowers B., Hutchinson P.E., Jones P.W., Fryer A.A., Strange R.C. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype. Cancer Epidemiol. Biomarkers Prev. 8:1999;61-67.
5. Ramachandran S., Fryer A.A., Smith A.G., Lear J.T., Bowers B., Griffiths C.E.M., Jones P.W., Strange R.C. Basal cell carcinoma: tumor clustering is associated with increased accrual in high-risk subgroups. Cancer. 89:2000;1012-1018.
6. Ramachandran S., Fryer A.A., Smith A.G., Lear J.T., Bowers B., Jones P.W., W P., Strange R.C. Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck. Cancer. 92:2001;354-358.
7. Karagas M.R., Greenberg E.R. Greenberg, Unresolved issues in the epidemiology of basal cell and squamous cell skin cancer. Mukhtar H. Skin Cancer: Mechanisms and Human Relevance. 1995;79-86 CRC Press, Boca Raton, FL.
8. Kricker A., Armstrong B.K., Jones M.E., Burton R.C. Health, Solar UV Radiation and Environmental Change. 1993;52-61 International Agency for Research on Cancer, Technical Report no 13, Lyon.
9. Ramachandran S., Fryer A.A., Smith A.G., Lear J.T., Bowers B., Hartland A.J., Whiteside J.R., Jones P.W., Strange R.C. Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype. Pharmacogenetics. 11:2001;1-8.
10. Fitzpatrick T.B. The validity and practicality of sun reaction skin types I through VI. Arch. Dermatol. 124:1988;869-871.
11. Ramachandran S., Fryer A.A., Lovatt T., Lear J.T., Smith A.G., Strange R.C. Susceptibility and modifier genes in cutaneous basal cell carcinomas and their associations with clinical phenotype. J. Photochem. Photobiol. 63:2001;1-7.
12. Perneger T.V. What's wrong with Bonferroni adjustments. Br. Med. J. 316:1998;1236-1238.
13. Rosenberger W.F. Dealing with multiplicities in pharmacoepidemiologic studies. Pharmacoepidem. Drug Saf. 5:1996;95-100.
14. Hiroi T., Imaoka S., Funae Y. Dopamine formation from Tyramine by CYP2D6. Biochem. Biophys. Res. Commun. 249:1998;838-843.
15. Reichrath J., Kamradt J., Zhu X.H., Kong X.F., Tilgen W., Holick M.F. Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas. Am. J. Pathol. 155:1999;583-589.
16. Kripke M.L. Ultraviolet radiation and immunology: s new under the sun. Cancer Res. 54:1994;6102-6105.